<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>38</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2000</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A new approach for the induction of vitiligo in mice</title>
    <FirstPage>25</FirstPage>
    <LastPage>28</LastPage>
    <AuthorList>
      <Author>
        <FirstName></FirstName>
        <LastName>Zehtab T</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>Rafieii Tehranie S</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>Yazdanparast R</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>09</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Tyrosinase has been recognized as a major autoantign in human vitiligo. Here we have shown that experimental autoimmune vitiligo can be induced by intradermal injection of mushroom tyrosinase emulsified in complete Freund&#x2019;s adjuvant in C57BL/6 mice. The onse of vitiligo was characterized by hair hypopigmentation and total melanocyte depletion in the basal layer of the epidermis. Our results confirm that tyrosinase is the causative autoantigen in the genesis of autoimmune vitiligo.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/2158</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/2158/2149</pdf_url>
  </Article>
</Articles>
